Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zoulim

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.
Journal of Viral Hepatitis|January 1, 1994
Selective detection of human hepatitis B virus surface and core antigens in peripheral blood mononuclear cell subsets by flow cytometryI Chemin, C Vermot-Desroches, I Baginski, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Journal of Viral Hepatitis|April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineF Zoulim, T Poynard, F Degos, et al.
Journal of Viral Hepatitis|March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patientsP Miailhes, P Pradat, M Chevallier, et al.
Journal of Viral Hepatitis|August 6, 2013
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarateP Pradat, M-A Le Pogam, J-B Okon, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusF Le Guerhier, C Pichoud, C Jamard, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replicationS Aguesse-Germon, S H Liu, M Chevallier, et al.
Gut|January 14, 2003
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrenceT Bizollon, S N S Ahmed, S Radenne, et al.
Journal of Hepatology|June 1, 1997
Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatomaC Gouillat, D Manganas, F Zoulim, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.
Journal of Viral Hepatitis|January 1, 1994
Selective detection of human hepatitis B virus surface and core antigens in peripheral blood mononuclear cell subsets by flow cytometryI Chemin, C Vermot-Desroches, I Baginski, et al.
Bone Marrow Transplantation|April 13, 2010
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTM Viganò, C Vener, P Lampertico, et al.
Journal of Viral Hepatitis|April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineF Zoulim, T Poynard, F Degos, et al.
Journal of Viral Hepatitis|March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patientsP Miailhes, P Pradat, M Chevallier, et al.
Journal of Viral Hepatitis|August 6, 2013
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarateP Pradat, M-A Le Pogam, J-B Okon, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusF Le Guerhier, C Pichoud, C Jamard, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replicationS Aguesse-Germon, S H Liu, M Chevallier, et al.
Gut|January 14, 2003
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrenceT Bizollon, S N S Ahmed, S Radenne, et al.
Journal of Hepatology|June 1, 1997
Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatomaC Gouillat, D Manganas, F Zoulim, et al.
Pageof 13